StartAngels Network

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.